Virtus Investment Advisers’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$427K Buy
13,799
+337
+3% +$8.29K 0.12% 238
2025
Q4
$281K Buy
13,462
+8,391
+165% +$156K 0.08% 270
2025
Q3
$79.6K Buy
5,071
+881
+21% +$18.2K 0.02% 434
2025
Q2
$83.3K Buy
4,190
+649
+18% +$13.2K 0.03% 410
2025
Q1
$62.7K Buy
+3,541
New +$115K 0.02% 461

Other funds holding TECX

Virtus Investment Advisers's TECX Position: Q1 2026 in Review

Virtus Investment Advisers increased its Tectonic Therapeutic (TECX) stake by 2.5% in Q1 2026, buying an estimated $8.29K and bringing the position to 13,799 shares worth $427K. The position accounts for 0.12% of the portfolio, ranked #238.

Virtus Investment Advisers first reported a position in TECX in Q1 2025 and has held it in 5 quarters since. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • Virtus Investment Advisers held 13,799 shares of Tectonic Therapeutic worth $427K as of Q1 2026.
  • Virtus Investment Advisers bought 337 Tectonic Therapeutic shares in Q1 2026, an estimated $8.29K.
  • Tectonic Therapeutic made up 0.12% of Virtus Investment Advisers's portfolio in Q1 2026, its #238 holding.
  • Virtus Investment Advisers first reported a position in Tectonic Therapeutic in Q1 2025 and has held it in 5 quarters since.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.